Another important consideration is that mitochondrial dysfunction is known to be impaired in PD patients beyond those with genetic mutations in the PINK1/Parkin pathway, so mitophagy enhancers may have a broader spectrum of application. This evidence concerns the gene PRKN and Parkinson disease.